Safety & Quality Standards at Fountain of Eden Wellness
Patient safety is the non-negotiable foundation of everything we do at Fountain of Eden Wellness. Led by Dr. Michele West-Harvey, MD, MPH, QIA — a certified Quality Improvement Associate — our clinic maintains rigorous treatment safety standards for every regenerative therapy we offer. From the sourcing of biologics to patient screening, sterile technique, real-time monitoring, and post-treatment follow-up, our safety protocols meet or exceed industry best practices.
Quality Improvement Associate (QIA) leadership ensures systematic, measurable safety processes
All biologics (stem cells, exosomes, secretome products) are sourced from FDA-registered tissue banks with full chain-of-custody documentation
Comprehensive patient screening before every treatment to identify contraindications and optimize outcomes
Sterile, controlled treatment environment with continuous monitoring during all procedures
Structured follow-up protocols and adverse event reporting for every patient
Transparent communication about risks, benefits, and realistic expectations
Why Does Safety Matter in Regenerative Medicine?
Regenerative medicine is one of the most promising and rapidly evolving fields in healthcare. Treatments like stem cell therapy, exosome therapy, and PRP therapy offer real potential for patients seeking alternatives to surgery, long-term medication, or conventional approaches that have plateaued.
However, as the field has grown, so has variability in how clinics operate. Not all regenerative medicine providers follow the same safety standards, source their biologics from the same quality suppliers, or screen patients with the same rigor.
At Fountain of Eden Wellness, regenerative medicine safety is not a marketing statement — it is a systematic discipline embedded into every step of the patient experience. Dr. West-Harvey’s certification as a Qualifications in Apheresis (QIA) means that our safety processes are designed, measured, and continuously improved using proven quality frameworks.
How Do We Ensure Stem Cell Therapy Safety?
Stem cell therapy safety begins long before the treatment itself. Our protocols address every stage of the process:
Sourcing of Biologics
The quality and safety of regenerative treatments depend heavily on the source materials. At Fountain of Eden:
- Stem cells and exosomes are obtained from FDA-registered suppliers that operate under Current Good Manufacturing Practices (cGMP)
- All products meet American Association of Tissue Banks (AATB) standards (or equivalent [ACCREDITATION BODY] standards)
- Every batch comes with a Certificate of Analysis (COA) documenting identity, purity, potency, and sterility testing
- Full chain-of-custody documentation tracks the product from donor screening through processing, storage, shipping, and administration
- Donor screening follows FDA-mandated protocols including comprehensive infectious disease testing and medical/social history review
Safety Checkpoint | What We Verify |
Donor Eligibility | FDA-compliant screening for infectious disease, medical history, social history |
Tissue Processing | cGMP facility, validated processing protocols |
Sterility Testing | USP <71> or equivalent sterility assays on every batch |
Potency Testing | Cell viability counts, bioactivity markers |
Chain of Custody | Documented from procurement through administration |
Storage & Handling | Temperature-controlled storage, validated shipping protocols |
PRP Safety
Platelet Rich Plasma therapy uses the patient’s own blood, eliminating donor compatibility concerns. Our PRP safety protocols include:
- FDA-cleared centrifuge and preparation systems
- Sterile, closed-system blood draw and processing
- Point-of-care preparation — your PRP is never sent off-site
- Standardized preparation protocols for consistent platelet concentration
What Are Our Patient Screening Procedures?
Not every patient is an appropriate candidate for every therapy. Our patient safety protocols begin with a rigorous screening process:
Pre-Treatment Evaluation
- Comprehensive medical history — including current medications, allergies, past surgeries, and previous treatment responses
- Physical examination — targeted assessment of the condition being treated
- Laboratory testing — baseline blood work including CBC, metabolic panel, inflammatory markers, and condition-specific labs
- Biological Age Assessment — when appropriate, to establish a baseline and guide treatment selection
- Imaging review — evaluation of relevant imaging studies (X-rays, MRI, ultrasound)
- Contraindication screening — systematic review for conditions that may preclude certain therapies
Contraindications We Screen For
We carefully evaluate for conditions that may affect treatment safety, including but not limited to:
- Active infection or sepsis
- Active or untreated malignancy
- Severe coagulopathy or blood disorders
- Pregnancy or planned pregnancy
- Severe allergic history to treatment components
- Certain immunosuppressive conditions (evaluated case by case)
- Unstable cardiovascular conditions
If any contraindication is identified, Dr. West-Harvey will discuss alternative approaches or modifications. We will never administer a treatment when the risk profile does not support it — even if the patient has requested it.
What Happens During Treatment?
Sterile Treatment Environment
All regenerative procedures are performed in a dedicated treatment suite that meets clinical standards for sterile procedures:
- Regularly sanitized and inspected treatment rooms
- Sterile instrument trays and single-use supplies
- Personal protective equipment (PPE) for all clinical staff
- Aseptic technique for all injections and IV administrations
Real-Time Patient Monitoring
During treatment, our clinical team monitors:
- Vital signs — heart rate, blood pressure, oxygen saturation, and temperature
- Patient comfort — continuous communication with the patient throughout the procedure
- Injection site response — monitoring for immediate adverse reactions
- IV infusion parameters — drip rate, infusion volume, and duration for IV vitamin infusions and IV-administered therapies
For shockwave therapy, parameters are adjusted in real-time based on patient tolerance and therapeutic targets.
Emergency Preparedness
Our clinic maintains:
- Emergency response protocols and equipment on-site
- Staff trained in Basic Life Support (BLS) and [ADDITIONAL CERTIFICATIONS]
- Emergency medication kit including epinephrine, antihistamines, and supportive care supplies
- Established relationships with local emergency departments for rapid transfer if ever needed
What Happens During Treatment?
Immediate Post-Treatment Monitoring
After any regenerative procedure, patients remain at the clinic for a supervised observation period. During this time, we monitor for:
- Allergic reactions or hypersensitivity
- Vasovagal responses
- Injection site reactions (swelling, bruising, discomfort)
- Any unexpected symptoms
Discharge Instructions
Every patient receives written discharge instructions that include:
- Expected post-treatment effects and timeline
- Warning signs that should prompt a call to our office
- Activity restrictions and recovery recommendations
- Medication and supplement guidance
- Emergency contact information for after-hours concerns
Follow-Up Protocols
- 48-72 hour check-in — phone or telehealth follow-up to assess initial response
- Scheduled follow-up appointments — at intervals appropriate to the treatment (typically 2 weeks, 6 weeks, 3 months, and 6 months)
- Objective outcome tracking — repeat diagnostics and assessments to measure treatment response
- Open communication — patients may contact our office at any time with questions or concerns
How Do We Handle Adverse Events?
While serious adverse events are rare with properly administered regenerative therapies, we maintain a formal adverse event protocol:
Immediate assessment and response
any reported adverse event is evaluated promptly by Dr. West-Harvey
Documentation
every adverse event is thoroughly documented in the patient record
Regulatory reporting
events meeting reporting thresholds are reported to appropriate regulatory bodies as required
Root cause analysis
Dr. West-Harvey’s QIA training ensures that every significant event triggers a systematic review to identify contributing factors and prevent recurrence
Patient communication
transparent, timely communication with the affected patient about what occurred and the steps being taken
What About FDA Compliance?
Patients often have questions about the regulatory status of regenerative therapies. We believe in full transparency:
- PRP therapy uses the patient’s own blood and FDA-cleared preparation devices
- IV vitamin infusions use FDA-approved pharmaceutical-grade compounds
- Peptide therapies are prescribed by Dr. West-Harvey and sourced from [COMPOUNDING PHARMACY NAME], a [ACCREDITATION — e.g., PCAB-accredited] compounding pharmacy
- Stem cells, exosomes, and secretome products are regulated as human cells, tissues, and cellular and tissue-based products (HCT/Ps) under FDA 21 CFR Part 1271. Our products are obtained through FDA-registered channels and processed in compliance with applicable regulations
- Shockwave therapy devices are FDA-cleared for musculoskeletal applications
We encourage patients to review the research and evidence page for additional context on the current state of clinical evidence for each therapy.
Quality Assurance & Continuous Improvement
Dr. West-Harvey’s Qualifications in Apheresis (QIA) certification is not just a credential — it’s an operational philosophy. Our quality assurance program includes:
- Standard Operating Procedures (SOPs) for every clinical and administrative process
- Regular protocol reviews to incorporate new evidence and best practices
- Patient outcome tracking with anonymized data analysis to identify trends and improvement opportunities
- Continuing education for all clinical staff
- Patient satisfaction assessments to continuously refine the experience
- Supplier and vendor audits to ensure ongoing quality of sourced materials
Our Safety Commitment to You
At Fountain of Eden Wellness, your safety is not secondary to innovation — it is the prerequisite for it. We will never compromise safety standards in pursuit of marketing trends, patient demand, or revenue. If a treatment is not appropriate for you, we will tell you honestly and help you explore alternatives.
This commitment extends to how we communicate. We do not make guarantee claims. We do not promise cures. We provide honest, evidence-based guidance and deliver treatments with the highest safety standards we can achieve.
Have questions about treatment safety? Dr. West-Harvey welcomes the opportunity to discuss our protocols during your initial consultation. Your peace of mind matters to us.